HLS in the World: New Technologies, New Dilemmas image

October 27, 2017 4:00 PM
Lectures and Panels
2017-2018
Austin East (101)
Harvard Law School, Cambridge, MA

This event was part of the HLS in the World sessions of HLS │200, a bicentennial summit of academic sessions and programs devoted to legal issues of pressing importance.

Panel Description

New technologies with implications for human health and enhancement are developing at breakneck speed, with fundamental changes in genomic medicine, reproductive technology, neuroscience, and even how we die. Each of these technologies raises important questions at the intersection of ethics, law, and politics. What role should the government have in regulating scientific innovation? How should we weigh potential risks and benefits, to individuals, vulnerable populations, and even the environment? Can these technologies be used to promote justice, or do they risk entrenching existing disparities? This group of speakers discussed these pressing questions, and more, from their perspectives as lawyers, scientists, and clinicians.

Panelists

  • I. Glenn Cohen '03, Professor of Law, Harvard Law School, and Faculty Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School

  • Judith Edersheim '85, Co-Founder and Co-Director of the Center for Law, Brain and Behavior, Massachusetts General Hospital; Assistant Clinical Professor of Psychiatry, Harvard Medical School; and attending Psychiatrist in the Department of Psychiatry, Massachusetts General Hospital

  • Atul Gawande, Executive Director, Ariadne Labs

  • Eric Lander, President and Founding Director, The Broad Institute of MIT and Harvard

  • Moderator: Carmel Shachar '10, Executive Director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School

This event was sponsored by Harvard Law School as part of the HLS │200 bicentennial celebrations.

Tags

bioethics   biotechnology   carmel shachar   end-of-life   enhancement   environment   genetics   health law policy   human rights   i. glenn cohen   innovation   medicine   neuroscience   public health   regulation   reproductive technologies   research